Leptospirosis in Latin America

Leptospirosis is a common disease in Latin America. Transmission to humans occurs by contact with water or soil contaminated with the urine of rodents, dogs, or livestock. Pathogenesis is still poorly understood, and bacterial toxin or virulence factors are probably responsible for many features of the disease. The anicteric form is the most frequent presentation, and its clinical picture resembles influenza or other acute febrile diseases. Icterohemorrhagic leptospirosis, or Weil's syndrome, represents the severe form of the disease. Its clinical picture is similar to bacterial sepsis and multiple organ involvement occurs, mainly in kidneys and lungs, and causes great morbidity and mortality. Death is often related to multiple organ failure and pulmonary hemorrhages. Diagnosis is based on serology or blood, cerebrospinal fluid and urine cultures in specific media. Treatment involves a combination of antibiotics and supportive measures.     

AIDS in Latin America

The epidemic in Latin America has placed an unexpected additional burden on the health care systems and national economies, already weak and affected by severe problems. Specific regional diseases in addition to common opportunistic infections, and particularly the high incidence of TB, produce a different picture compared with the United States and Europe. Access to ARV therapy is far from being universal in Latin America; nevertheless, some countries are providing HAART to all eligible patients, showing that it is not impossible to improve quality of care for people living with HIV infection in the region. Before assuming as definitive and irreversible that at least one or two generations will be sacrificed on the altar of inequity of our uneven world, we as acting scientists should join the struggle of millions of human beings claiming their right to be treated with the best drugs that science can offer today.     

Hepatitis E in Latin America

Hepatitis E virus produces an emerging health problem, knowledge about epidemiology of hepatitis E virus infections in the USA and Latin America is still limited. The wide-ranging clinical manifestations lead to an extensive underestimation of the global seroprevalence. Clinical and diagnostic accuracy are critical to improve patient management.     

Gastroenterology training in Latin America

Latin America is characterized by ethnic, geographical, cultural, and economic diversity; therefore, training in gastroenterology in the region must be considered in this context. The continent’s medical education is characterized by a lack of standards and the volume of research continues to be relatively small. There is a multiplicity of events in general gastroenterology and in sub-disciplines, both at regional and local levels, which ensure that many colleagues have access to information. Medical educat...     

Gastric cancer in Latin America

Every year, cancer affects more than one million Latin Americans. The increasing incidence of cancer could be secondary to an aging population, westernization of life style, and urbanization. LA has among the highest incidence rates of gastric cancer, compared to other countries. In this review, different studies on gastric cancer and its relation with risks factors, such as infections, diet and life styles typical of LA, besides the different molecular alterations of that specific population (mainly at a genetic polymorphism level) are analyzed. An exhaustive research was made in PubMed, MEDLINE and Embase of the most relevant studies conducted in the last 27 years (1990–2017) in LA.     

Diabetes trends in Latin America

The incidence of type 1 diabetes in Latin America ranges from 0.4 to 8.3 cases per 100000 children under 15 years of age, and the prevalence of type 2 diabetes ranges from 1.2% to 8%, with higher prevalence rates in urban areas. The frequency of diabetes in Latin America is expected to increase by 38% over the next 10 years, compared with an estimated 14% increase in the total population. The total number of cases of diabetes is expected to more than double and to exceed the number of cases in the US, Canada, and Europe by 2025. Factors underlying this increase include aging and increased life expectancy of the population, increased urbanization, and lifestyle changes among Native American populations. In many places, only a minority of individuals currently receives treatment for diabetes. Furthermore, the diagnosis of type 2 diabetes often occurs late in the course of the disease, with the result that 10-40% of patients have chronic complications at the time of diagnosis. Hospital costs account for most direct expenditures associated with treatment, and mortality associated with diabetes has increased markedly in some areas over the past 2 decades.     

Prenatal care in Latin America

Available data on the coverage of prenatal care in Latin America were reviewed. In recent years, only Bolivia had a coverage of prenatal care of less than 50 per cent. More than 90 per cent of pregnant women received prenatal care in Chile, Cuba, the Dominican Republic, and Puerto Rico. Prenatal care increased between the 1970 and 1980 in the Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, and Peru. The coverage of prenatal care decreased in Bolivia and Colombia. The mean number of visits increased in Cuba and Puerto Rico. The increase of prenatal care in Guatemala and Honduras is due to increased care by traditional birth attendants, compared to the role of health care institutions. We compared the more recent data on tetanus immunization of pregnant women to the more recent data on prenatal care. The rates of tetanus immunization are always lower than the rates of prenatal care attendance, except in Costa Rica. The rates of tetanus immunization was less than half as compared to the rates of prenatal care in Bolivia, Guatemala, and Peru. To improve the content of prenatal care should be an objective complementary to the increase of the number of attending women.     

Diffuse panbronchiolitis in Latin America

Diffuse panbronchiolitis (DPB) is a unusual form of bronchiolar disease that has been reported almost exclusively in Asians. We describe DPB in a non-Asian Brazilian citizen who has never traveled outside the country. The clinical, radiographic, and histologic features of this case resemble those described in Japanese patients. The present case shows that DPB, although rare in Western countries, is not a disease restricted to Asia. It always should be considered in the differential diagnosis of nodular radiographic opacities associated with airflow limitation, especially in non-smokers with a history of chronic sinusitis.     

Laser lead extraction in octo- and nonagenarians. A subgroup analysis from the GALLERY registry

Introduction

In an aging population with cardiac implantable electronic devices, an increasing number of octo- and even nonagenarians present for lead extraction procedures. Those patients are considered at increased risk for surgical procedures including lead extraction. Here, we investigated safety and efficacy of transvenous lead extraction in a large patient cohort of octo- and nonagenarians.

Methods and Results

A subgroup analysis of all patients aged ≥80 years (n = 499) in the German Laser Lead Extraction Registry (GALLERY) was performed. Outcomes were compared to the nonoctogenarians from the registry. Primary extraction method was Laser lead extraction, with additional use of mechanical rotational sheaths or femoral snares, if necessary. An analysis of patient- and device characteristics, as well as an assessment of predictors for adverse events via multivariate analyses was conducted. Mean patients age was 84.3 ± 3.7 years in the octogenarians group and 64.1 ± 12.4 years in the nonoctogenarians group. The median lead dwell time was 118.0 months (78; 167) and 92.0 months [60; 133], p < .001 in the octogenarians and nonoctogenarians group, respectively. Clinical procedural success rate was achieved in 97.6% of the cases in octogenarians and 97.9% in nonoctogenarians (p = .70). Overall complication rate was 4.4% in octogenarians and 4.3% in nonoctogenarians (0.91). In octogenarians procedure-related mortality was 0.8% and all-cause in-hospital mortality was 5.4%, while in nonoctogenarians, procedure related and all-cause in-hospital mortality were 0.5% and 3.1%, respectively. A body mass index (BMI) <20 kg/m², was the only statistically significant predictor for procedure-related complications in octogenarians, while systemic infection, BMI ≤20 kg/m², procedural complications and chronic kidney disease were predictors for in-hospital mortality.

Conclusions

Laser lead extraction in octo- and nonagenarians is safe and effective. BMI ≤20 kg/m² was the only statistically significant predictor for procedural complications. According to our data, advanced age should not be considered as contraindication for laser lead extraction.     

Serial Defibrillation Lead Impedance in Patients with Epicardial and Nonthoracotomy Lead Systems

Lead Impedance in ICDs. Introduction: The stability of implantable cardiac defibrillation lead impedance subsequent to implantation has not been reported and may have important clinical implications. The objective was to characterize the incidence and degree of impedance changes occurring after implantation of defibrillation lead systems. Methods and Results: The study cohort consisted of patients who received epicardial or nonthoracotomy lead systems. Defibrillation impedance was recorded at implantation, prior to hospital discharge (predischarge), and during follow-up. For each individual the magnitude of the impedance change relative to implantation was characterized. Among patients with an epicardial system, a significant decrease in impedance was observed at predischarge (mean 9.3 Ω). The magnitude of the decrease was large in 39% and moderate in 31% of individuals. Subsequently, a gradual rise in mean impedance was apparent. At 18–21 months postimplantation, impedance was significantly increased relative to implantation (mean 6.8 ω). At this time, the magnitude of the increase was large in 46% and moderate in 23% of patients. Among patients with a nonthoracotomy lead system including a subcutaneous patch, a significant decrease in mean impedance was observed at predischarge (mean 3.5 ω). The magnitude of the decrease was large in 8% and moderate in 50% of individuals. Subsequently, a gradual rise in impedance was apparent. At 5–6 months, it was significantly increased relative to implantation (mean 2.3 ω). The magnitude of the increase was large in 10% and moderate in 33% of patients. Among the group of patients whose nonthoracotomy lead system did not include a subcutaneous patch, there was no significant change in mean impedance at predischarge relative to implantation. In subsequent intervals, a gradual rise was apparent. At 5–6 months, impedance was significantly increased relative to implantation (mean 4.3 ω). The magnitude of the increase was large in 16% and moderate in 47% of individuals. Conclusion: Significant changes in defibrillation lead impedance occur after implantation of epicardial and nonthoracotomy defibrillation lead systems. These data may serve as a standard for identifying the anticipated maximum change in lead impedance and thus may be useful as a tool for recognizing problems with defibrillation lead integrity.